OGSIVEO (nirogacestat) FDA Approved for Desmoid Tumors, Available at Biologics by McKesson

CARY, N.C., Dec. 5, 2023 —Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease, was selected by SpringWorks Therapeutics as a limited distribution specialty pharmacy for OGSIVEOTM (nirogacestat), which is a gamma secretase inhibitor indicated for adult pa...
Source: McKesson News - Category: Information Technology Source Type: news